{
    "applicationNumber": "BR 11 2020 026976-0",
    "filingDate": "28/06/2019",
    "grantDate": null,
    "title": "PRODUTO COMBINADO E COMPLEXO PARA POTENCIALIZAREM UMA RESPOSTA IMUNE, USO DO COMPLEXO, COMPOSI\u00c7\u00c3O DE VACINA E COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA, M\u00c9TODO QUE PROMOVE RESPOSTA IMUNE IN VIVO A UM ANT\u00cdGENO EM UM HOSPEDEIRO",
    "nationalPhaseDate": [
        "29/12/2020"
    ],
    "internationalApplication": {
        "pctNumber": "PCT CN2019/093558",
        "pctDate": "28/06/2019",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "CN",
            "priorityNumber": "201810700708.6",
            "priorityDate": "29/06/2018"
        },
        {
            "countryCode": "CN",
            "priorityNumber": "201810698033.6",
            "priorityDate": "29/06/2018"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2610"
        },
        {
            "code": "1.5",
            "description": "Exig\u00eancias Diversas",
            "bulletinNumber ": "2621"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2629"
        }
    ],
    "inventors": [
        "HAIXIANG LIN",
        "FANG LIU",
        "LI ZHA"
    ],
    "holders": [
        279598
    ],
    "ipcCodes": [
        "A61P 31/04",
        "A61P 35/00",
        "A61K 47/02",
        "A61P 31/12",
        "A61K 47/26",
        "A61P 37/04",
        "A61K 39/39",
        "A61K 31/713",
        "A61K 45/06"
    ]
}